Cite
HARVARD Citation
Fulton, B. et al. (2018). PARADIGM-2: Two parallel phase I studies of olaparib and radiotherapy or olaparib and radiotherapy plus temozolomide in patients with newly diagnosed glioblastoma, with treatment stratified by MGMT status. Clinical and translational radiation oncology. pp. 12-16. [Online].